Schedule 13G ownership disclosure

TRAVERE THERAPEUTICS INC

Security class unavailable · CUSIP: 89422G107

Event date: 2021-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001172661-22-000428
Form type
SC 13G/A
Filer
Deep Track Capital, LP
CIK
CIK 1856083
Filed
Feb 14, 2022
Reporting period
Dec 31, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub